Report

Global Opioids Market Size study & Forecast, by Product Type (Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Others), by Application (Pain Management, Cough Treatment, Diarrhea Treatment) and Regional Analysis, 2022-2029

  • Publish Date: Feb,2023
  • Report ID: 3-2-1563
  • Page : 200
  • Report Type : PDF (Email)
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Opioids Market, by Region, 2019-2029 (USD Billion)
1.2.2. Opioids Market, by Product Type, 2019-2029 (USD Billion)
1.2.3. Opioids Market, by Application, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Opioids Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Opioids Market Dynamics
3.1. Opioids Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising number of product approval and the introduction of novel opioid medicines
3.1.1.2. Increasing incidences of chronic pains among the population
3.1.2. Market Challenges
3.1.2.1. Execution of stringent government regulations for opioid prescription
3.1.2.2. Rise in opioid addiction (opioid crisis)
3.1.3. Market Opportunities
3.1.3.1. Growing investments in R&D activities
3.1.3.2. Increasing healthcare expenditure
Chapter 4. Global Opioids Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Opioids Market, by Product Type
6.1. Market Snapshot
6.2. Global Opioids Market by Product Type, Performance - Potential Analysis
6.3. Global Opioids Market Estimates & Forecasts by Product Type 2019-2029 (USD Billion)
6.4. Opioids Market, Sub Segment Analysis
6.4.1. Methadone
6.4.2. Codeine
6.4.3. Fentanyl
6.4.4. Oxycodone
6.4.5. Morphine
6.4.6. Hydrocodone
6.4.7. Others
Chapter 7. Global Opioids Market, by Application
7.1. Market Snapshot
7.2. Global Opioids Market by Application, Performance - Potential Analysis
7.3. Global Opioids Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
7.4. Opioids Market, Sub Segment Analysis
7.4.1. Pain Management
7.4.2. Cough Treatment
7.4.3. Diarrhea Treatment
Chapter 8. Global Opioids Market, Regional Analysis
8.1. Opioids Market, Regional Market Snapshot
8.2. North America Opioids Market
8.2.1. U.S. Opioids Market
8.2.1.1. Product Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Opioids Market
8.3. Europe Opioids Market Snapshot
8.3.1. U.K. Opioids Market
8.3.2. Germany Opioids Market
8.3.3. France Opioids Market
8.3.4. Spain Opioids Market
8.3.5. Italy Opioids Market
8.3.6. Rest of Europe Opioids Market
8.4. Asia-Pacific Opioids Market Snapshot
8.4.1. China Opioids Market
8.4.2. India Opioids Market
8.4.3. Japan Opioids Market
8.4.4. Australia Opioids Market
8.4.5. South Korea Opioids Market
8.4.6. Rest of Asia Pacific Opioids Market
8.5. Latin America Opioids Market Snapshot
8.5.1. Brazil Opioids Market
8.5.2. Mexico Opioids Market
8.5.3. Rest of Latin America Opioids Market
8.6. Rest of The World Opioids Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Teva Pharmaceutical Industries Limited
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Purdue Pharma LP
9.2.3. AstraZeneca Plc
9.2.4. C.H. Boehringer Sohn Ag and Co. Kg
9.2.5. Johnson & Johnson, Inc.
9.2.6. Sanofi S.A.
9.2.7. Mallinckrodt Pharmaceuticals
9.2.8. Endo Pharmaceuticals Inc.
9.2.9. Pfizer, Inc.
9.2.10. Sun Pharmaceuticals Industries Limited
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption